Peer-reviewedCC BY-NC-NDTranslational cancer research
Extracellular adenosine triphosphate upregulates S100A4 expression and promotes the migration and invasion of breast cancer cells via P2Y2/SOX9 signaling
- 1Department of Thoracic Surgery , The First Affiliated Hospital of Kunming Medical University , Kunming , ;
- 2Department of Pathology , The Third Affiliated Hospital of Kunming Medical University , Yunnan Cancer Hospital , Peking University Cancer Hospital Yunnan , Kunming , ;
- 3Yunnan Key Laboratory of Breast Cancer Precision Medicine , Yunnan Cancer Hospital , The Third Affiliated Hospital of Kunming Medical University , Peking University Cancer Hospital Yunnan , Kunming , ;
Related
- Plasma adenosine triphosphate and heat shock protein 72 concentrations after aerobic and eccentric exercise.
- The antidepressant-like effect of adenosine A1 receptor over-expression in forebrain neurons does not involve an altered adenosine-mediated control of excitatory synaptic transmission
- HDAC1 inhibits CDX2 expression and promotes colorectal cancer cell migration
- Pharmacological melatonin induces mitochondrial dysfunction and alters extracellular nucleotide metabolism and CD39/CD73 expression in human melanoma cells.
- Extracellular GPX3 drives insulin receptor expression in adipose tissue independent of its peroxidase activity
BibTeX
@article{cui2026extracellular,
title = {{Extracellular adenosine triphosphate upregulates S100A4 expression and promotes the migration and invasion of breast cancer cells via P2Y2/SOX9 signaling}},
author = {Yue Cui and Fengming Ran and Guangxiong Ruan and Sheng Huang and Ying Liu},
journal = {Translational cancer research},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13657837},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Extracellular adenosine triphosphate upregulates S100A4 expression and promotes the migration and invasion of breast cancer cells via P2Y2/SOX9 signaling
AU - Yue Cui
AU - Fengming Ran
AU - Guangxiong Ruan
AU - Sheng Huang
AU - Ying Liu
PY - 2026
DA - 2026/09/20
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657837
SN - 2218-676X
ER -